Post-pandemic Era-Global Biological Drugs Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Report Code : XYZ2438563
- Published On: Apr, 2021
- Category : Medical Devices
- Pages : 101
-
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Research’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Biological Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Biological Drugs Market Include by
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Biological Drugs Market
Roche
Amgen
Novo Nordisk
Abbott Laboratories
Pfizer
Novartis
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter
Major Type of Biological Drugs Covered in Research report:
Gardasil
Prenvar 13
Fluzone
Cervarix
Varivax
Application Segments Covered in Research Market
Auto-Immune Diseases
Blood Diseases
Cancer-Related Conditions
Diabetes
Cardiovascular Diseases
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide Post pandemic Era Global Biological Drugs market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Biological Drugs Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope1.1 Product Details and Introduction
1.1.1 Gardasil -Product Introduction and Major Manufacturers
1.1.2 Prenvar 13 -Product Introduction and Major Manufacturers
1.1.3 Fluzone -Product Introduction and Major Manufacturers
1.1.4 Cervarix -Product Introduction and Major Manufacturers
1.1.5 Varivax -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis2.1 China Biological Drugs Status and Prospect (2016-2027)
2.1.1 China Biological Drugs Market Size and Growth Rate (2016-2027)
2.1.2 China Biological Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)2.2 EU Biological Drugs Status and Prospect (2016-2027)
2.2.1 EU Biological Drugs Market Size and Growth Rate (2016-2027)
2.2.2 EU Biological Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)2.3 USA Biological Drugs Status and Prospect (2016-2027)
2.3.1 USA Biological Drugs Market Size and Growth Rate (2016-2027)
2.3.2 USA Biological Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)2.4 Japan Biological Drugs Status and Prospect (2016-2027)
2.4.1 Japan Biological Drugs Market Size and Growth Rate (2016-2027)
2.4.2 Japan Biological Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)2.5 India Biological Drugs Status and Prospect (2016-2027)
2.5.1 India Biological Drugs Market Size and Growth Rate (2016-2027)
2.5.2 India Biological Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)2.6 Southeast Asia Biological Drugs Status and Prospect (2016-2027)
2.6.1 Southeast Asia Biological Drugs Market Size and Growth Rate (2016-2027)
2.6.2 Southeast Asia Biological Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Biological Drugs Status and Prospect (2016-2027)
2.7.1 South America Biological Drugs Market Size and Growth Rate (2016-2027)
2.7.2 South America Biological Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Biological Drugs Status and Prospect (2016-2027)
2.8.1 Biological Drugs Market Size and Growth Rate (2016-2027)
2.8.2 Biological Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Biological Drugs Market Assessment by Segment3.1 Global Biological Drugs Capacity and Growth Rate
3.2 Global Biological Drugs Sales by Type
3.3 Global Biological Drugs Sales Revenue by Type
3.4 Global Biological Drugs Consumption by Application
4 Global Biological Drugs Market Assessment by Regions4.1 Global Biological Drugs Production Analysis and Forecast by Regions (2016-2027)
4.2 Global Biological Drugs Sales Analysis and Forecast by Regions (2016-2027)
4.3 Global Biological Drugs Sales Revenue Analysis and Forecast by Regions (2016-2027)
5 Value Chain (Impact of COVID-19)5.1 Biological Drugs Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream5.2 COVID-19 Impact on Biological Drugs Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape6.1 Global Biological Drugs Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Biological Drugs Sales Market Share of Manufacturers (2019-2020)
6.3 Global Biological Drugs Sales Revenue Market Share of Manufacturers (2019-2020)
7 Biological Drugs Competitive Analysis7.1 Roche
7.1.1 Roche Company Profiles
7.1.2 Roche Product Introduction
7.1.3 Roche Biological Drugs Production, Revenue (2015-2020)
7.1.4 SWOT Analysis7.2 Amgen
7.2.1 Amgen Company Profiles
7.2.2 Amgen Product Introduction
7.2.3 Amgen Biological Drugs Production, Revenue (2015-2020)
7.2.4 SWOT Analysis7.3 Novo Nordisk
7.3.1 Novo Nordisk Company Profiles
7.3.2 Novo Nordisk Product Introduction
7.3.3 Novo Nordisk Biological Drugs Production, Revenue (2015-2020)
7.3.4 SWOT Analysis7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Profiles
7.4.2 Abbott Laboratories Product Introduction
7.4.3 Abbott Laboratories Biological Drugs Production, Revenue (2015-2020)
7.4.4 SWOT Analysis7.5 Pfizer
7.5.1 Pfizer Company Profiles
7.5.2 Pfizer Product Introduction
7.5.3 Pfizer Biological Drugs Production, Revenue (2015-2020)
7.5.4 SWOT Analysis7.6 Novartis
7.6.1 Novartis Company Profiles
7.6.2 Novartis Product Introduction
7.6.3 Novartis Biological Drugs Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Eli Lilly
7.7.1 Eli Lilly Company Profiles
7.7.2 Eli Lilly Product Introduction
7.7.3 Eli Lilly Biological Drugs Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Profiles
7.8.2 Bristol-Myers Squibb Product Introduction
7.8.3 Bristol-Myers Squibb Biological Drugs Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Biogen
7.9.1 Biogen Company Profiles
7.9.2 Biogen Product Introduction
7.9.3 Biogen Biological Drugs Production, Revenue (2015-2020)
7.9.4 SWOT Analysis7.10 Baxter
7.10.1 Baxter Company Profiles
7.10.2 Baxter Product Introduction
7.10.3 Baxter Biological Drugs Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
8 Conclusion
-
The Post pandemic Era Global Biological Drugs Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the Post pandemic Era Global Biological Drugs Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
Depending upon the type of applications, the Post pandemic Era Global Biological Drugs Market has been segmented into
The Post pandemic Era Global Biological Drugs Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Post pandemic Era Global Biological Drugs Market as well as its distribution among its players
The Post pandemic Era Global Biological Drugs study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.
